REYKJAVIK, Iceland, Feb. 17 /PRNewswire-FirstCall/ -- deCODE genetics today announced that its presentation at the BIO CEO & Investor Conference 2005 will be webcast live via streaming audio. deCODE CEO Dr. Kari Stefansson will provide an overview of the company's drug development programs and business.
The presentation will be delivered at 2pm EST/7pm GMT on Thursday, February 24, 2005, at the Waldorf Astoria Hotel in New York City. The webcast can be accessed through the Investors page on deCODE's website, http://www.decode.com/. The webcast will be archived for at least one week on deCODE's website. Those interested in listening should log on a few minutes in advance, in order to download any software or complete any sign-in that may be required.
About deCODE
deCODE is a biopharmaceutical company applying its discoveries in human genetics to the development of drugs for common diseases. deCODE is a global leader in gene discovery -- our population approach and resources have enabled us to isolate key genes contributing to major public health challenges from cardiovascular disease to cancer, genes that are providing us with drug targets rooted in the basic biology of disease. deCODE is also leveraging its expertise in human genetics and integrated drug discovery and development capabilities to offer innovative products and services in DNA-based diagnostics, bioinformatics, genotyping, structural biology, drug discovery and clinical development. deCODE is delivering on the promise of the new genetics(SM). Visit us on the web at http://www.decode.com/.
Contact: deCODE genetics Kristin Asgeirsdottir +354 570 1950 ir@decode.is
deCODE genetics
The presentation will be delivered at 2pm EST/7pm GMT on Thursday, February 24, 2005, at the Waldorf Astoria Hotel in New York City. The webcast can be accessed through the Investors page on deCODE's website, http://www.decode.com/. The webcast will be archived for at least one week on deCODE's website. Those interested in listening should log on a few minutes in advance, in order to download any software or complete any sign-in that may be required.
About deCODE
deCODE is a biopharmaceutical company applying its discoveries in human genetics to the development of drugs for common diseases. deCODE is a global leader in gene discovery -- our population approach and resources have enabled us to isolate key genes contributing to major public health challenges from cardiovascular disease to cancer, genes that are providing us with drug targets rooted in the basic biology of disease. deCODE is also leveraging its expertise in human genetics and integrated drug discovery and development capabilities to offer innovative products and services in DNA-based diagnostics, bioinformatics, genotyping, structural biology, drug discovery and clinical development. deCODE is delivering on the promise of the new genetics(SM). Visit us on the web at http://www.decode.com/.
Contact: deCODE genetics Kristin Asgeirsdottir +354 570 1950 ir@decode.is
deCODE genetics
